Bolton

'A weather-map of popular feeling': how Mass-Observation was born

Retrieved on: 
Thursday, July 27, 2023

What if some people, even lots of people, were tensely watching “the racing news and daily horoscope”?

Key Points: 
  • What if some people, even lots of people, were tensely watching “the racing news and daily horoscope”?
  • This is the question posed by Mass-Observation at the start of the 1939 book, Britain.
  • I first came across Mass-Observation while doing my doctoral research in the 1990s and became a trustee in 2022.
  • But unlike social media, Mass-Observers – as the project’s voluntary contributors are known – write with posterity in mind, and write at length, anonymously and with candour.

Candour and idiosyncrasies

    • To this end, people were invited to volunteer to answer directives, to write diaries on specific days and to observe and describe the world around them.
    • The first Mass-Observation material I worked on, in the 1990s, was a microfiche file entitled Bad Dreams and Nightmares.
    • These accounts had been collated a few months before the start of the second world war, in an attempt to gauge social anxiety.
    • Reading the 66 reports that observers had sent in, however, had a cumulative effect of gnawing unease.

Archive of feelings

    • By the mid-1950s, it had stopped using a national panel of voluntary writers and slowly shut up shop.
    • Mass-Observation found a new lease of life in the mid-1970s when Harrisson bequeathed the archive to the University of Sussex, for safekeeping and public use.
    • It represents an invaluable archive for future historians.
    • Mass-Observation is a growing archive of feelings.

VitalHub Announces Licensing Agreement of Pre-Op Solutions, Synopsis Home and Synopsis iQ, to Bolton NHS Foundation Trust

Retrieved on: 
Monday, August 22, 2022

TORONTO, Aug. 22, 2022 (GLOBE NEWSWIRE) -- VitalHub Corp. (the Company or VitalHub) (TSX: VHI | OTCQX: VHIBF) is pleased to announce a licensing agreement of subsidiary Intouch with Healths (Intouch) digital, at-home pre-op solutions, Synopsis Home and Synopsis iQ, to the Bolton NHS Foundation Trust (the Trust or Bolton).

Key Points: 
  • TORONTO, Aug. 22, 2022 (GLOBE NEWSWIRE) -- VitalHub Corp. (the Company or VitalHub) (TSX: VHI | OTCQX: VHIBF) is pleased to announce a licensing agreement of subsidiary Intouch with Healths (Intouch) digital, at-home pre-op solutions, Synopsis Home and Synopsis iQ, to the Bolton NHS Foundation Trust (the Trust or Bolton).
  • This sale responds to a need identified by Bolton NHS Foundation Trust to alleviate their elective care backlog, increasing operational efficiency and throughput.
  • In turn, the Company expects the deployment of the Synopsis solutions to empower the Trust to better manage its elective backlog pressures.
  • We are excited to begin working with Bolton NHS Foundation Trust, as we continue to grow our customer base, said Dan Matlow, CEO of VitalHub Corp.

Titanium Transportation Expands US Network to the Western Market, By Opening Fourth US Freight Brokerage Office in 27 Months in Denver, CO

Retrieved on: 
Thursday, August 19, 2021

This marks the Companys fourth freight brokerage office in a major U.S. transportation and logistics geographic hub within the last 27 months.

Key Points: 
  • This marks the Companys fourth freight brokerage office in a major U.S. transportation and logistics geographic hub within the last 27 months.
  • We are extremely pleased with the performance of our US operations since entering the market 27 months ago and remain enthusiastic about opening additional brokerage centers.
  • In February 2021, Titanium completed its strategic acquisition of International Truckload Services Group, establishing Titanium among the largest Canadian transportation companies.
  • Titanium is a recognized consolidator of asset-based transportation companies in Ontario, having completed eleven (11) asset-based trucking acquisitions since 2011.

CEOs of Own Your Space and Spencer Churchill Law Ltd Invest £2m to Create a Bolton Business Quarter

Retrieved on: 
Thursday, July 15, 2021

A pair of entrepreneurial brothers, Adam and Dominic Pope, have invested an impressive 2m in a bid to rejuvenate Boltons business scene.

Key Points: 
  • A pair of entrepreneurial brothers, Adam and Dominic Pope, have invested an impressive 2m in a bid to rejuvenate Boltons business scene.
  • The brothers, both born in Bolton, are successful businessmen in their own right; Adam is the director of Spencer Churchill Law Ltd and Dominic runs digital marketing firm Own Your Space .
  • Adam explained: Our long-term vision is to create a business hub in the Trinity area, we want to encourage business to be based here and keep the Bolton pound in Bolton.
  • Spencer Churchill Law Ltd is directed by Adam Pope, and is also based in the heart of Bolton.

UPDATE -- PurMinds Completes Initial Strategic Equity Investment in Israeli Psychedelic Drug Company IMIO Life

Retrieved on: 
Wednesday, July 7, 2021

This equity financing positions PurMinds for accelerated growth in the burgeoning psychedelic biopharma sector.

Key Points: 
  • This equity financing positions PurMinds for accelerated growth in the burgeoning psychedelic biopharma sector.
  • On June 13, 2021, and pursuant to the Share Purchase Agreement, PurMinds completed a significant seed funding investment in IMIO Life as the sole equity investor of the psychedelic subsidiary of Israeli pharmaceutical development company Nextage Therapeutics.
  • Following the completion of the investment, PurMinds now holds approximately 13% of the issued and paid-up share capital of IMIO.
  • Except as required by law, the Company does not intend and does not assume any obligation to update this forward-looking information.

PurMinds Completes Initial Strategic Equity Investment in Psychedelic Drug Company IMIO Life

Retrieved on: 
Tuesday, July 6, 2021

Toronto, Ontario, July 06, 2021 (GLOBE NEWSWIRE) -- PurMinds BioPharma Inc. (PurMinds or the Company), a Canadian biopharma company with a special focus on novel drug development for neurodegenerative diseases with significant unmet medical needs, announced today the completion of its strategic equity investment in IMIO Life Ltd., the psychedelic pharmaceutical subsidiary of leading Israeli innovative drug research and development company Nextage Therapeutics Ltd. (TASE: NXTG).

Key Points: 
  • Toronto, Ontario, July 06, 2021 (GLOBE NEWSWIRE) -- PurMinds BioPharma Inc. (PurMinds or the Company), a Canadian biopharma company with a special focus on novel drug development for neurodegenerative diseases with significant unmet medical needs, announced today the completion of its strategic equity investment in IMIO Life Ltd., the psychedelic pharmaceutical subsidiary of leading Israeli innovative drug research and development company Nextage Therapeutics Ltd. (TASE: NXTG).
  • This equity financing positions PurMinds for accelerated growth in the burgeoning psychedelic biopharma sector.
  • On June 13, 2021, and pursuant to the Share Purchase Agreement, PurMinds completed a significant seed funding investment in IMIO Life as the sole equity investor of the psychedelic subsidiary of Israeli pharmaceutical development company Nextage Therapeutics.
  • Following the completion of the investment, PurMinds now holds approximately 13% of the issued and paid-up share capital of IMIO.

PurMinds Completes Initial Strategic Equity Investment in Psychedelic Drug Company IMIO Life

Retrieved on: 
Tuesday, July 6, 2021

Toronto, Ontario, July 06, 2021 (GLOBE NEWSWIRE) -- PurMinds BioPharma Inc. (PurMinds or the Company), a Canadian biopharma company with a special focus on novel drug development for neurodegenerative diseases with significant unmet medical needs, announced today the completion of its strategic equity investment in IMIO Life Ltd., the psychedelic pharmaceutical subsidiary of leading Israeli innovative drug research and development company Nextage Therapeutics Ltd. (TASE: NXTG).

Key Points: 
  • Toronto, Ontario, July 06, 2021 (GLOBE NEWSWIRE) -- PurMinds BioPharma Inc. (PurMinds or the Company), a Canadian biopharma company with a special focus on novel drug development for neurodegenerative diseases with significant unmet medical needs, announced today the completion of its strategic equity investment in IMIO Life Ltd., the psychedelic pharmaceutical subsidiary of leading Israeli innovative drug research and development company Nextage Therapeutics Ltd. (TASE: NXTG).
  • This equity financing positions PurMinds for accelerated growth in the burgeoning psychedelic biopharma sector.
  • On June 13, 2021, and pursuant to the Share Purchase Agreement, PurMinds completed a significant seed funding investment in IMIO Life as the sole equity investor of the psychedelic subsidiary of Israeli pharmaceutical development company Nextage Therapeutics.
  • Following the completion of the investment, PurMinds now holds approximately 13% of the issued and paid-up share capital of IMIO.

Bolton Technical Re-launches Website Featuring eCommerce Sales And A New Interactive Catalog For B2C And B2B Sales

Retrieved on: 
Thursday, May 27, 2021

HOUSTON, May 27, 2021 /PRNewswire/ --Houston-based Bolton Technical has rebooted their BoltonTechnical.com site to feature a new brand identity, new products, a new catalog and providing the ability to buy online.

Key Points: 
  • HOUSTON, May 27, 2021 /PRNewswire/ --Houston-based Bolton Technical has rebooted their BoltonTechnical.com site to feature a new brand identity, new products, a new catalog and providing the ability to buy online.
  • Bolton Technical has relaunched BoltonTechnical.com with a new brand, new products, and eCommerce selling capabilities.
  • Also, there is an opportunity for distributors, retailers, integrators, and installers to partner with Bolton Technical to enhance their product offerings by connecting with a B2B expert at BoltonTechnical.com.
  • Contact the BoltonTechnical.com Marketing Team; via email at [email protected] or by calling toll-free at 888-987-2658; for international calls, please dial +1 281-310-5929
    Bolton Technical Global Headquarters are at:
    Bolton Technical may be found online at:

Headwall Joins as Industry Partner for NSF Internet of Things for Precision Agriculture

Retrieved on: 
Thursday, April 22, 2021

b'Bolton, Massachusetts, April 22, 2021 (GLOBE NEWSWIRE) -- Headwall , the industry leader in turnkey hyperspectral imaging (HSI) solutions, is pleased to announce collaborating as a member of the Industrial Practitioner Advisory Board for NSF-funded Internet of Things for Precision Agriculture (IoT4Ag) .

Key Points: 
  • b'Bolton, Massachusetts, April 22, 2021 (GLOBE NEWSWIRE) -- Headwall , the industry leader in turnkey hyperspectral imaging (HSI) solutions, is pleased to announce collaborating as a member of the Industrial Practitioner Advisory Board for NSF-funded Internet of Things for Precision Agriculture (IoT4Ag) .
  • In an increasingly connected environment, the Internet of Things has critical implications for sensor development and deployment in the field,\xe2\x80\x9d said David Bannon, Headwall President & CEO.
  • With a worldwide base of end-user and OEM customers, Headwall enjoys a market leadership position through the design and manufacture of spectral solutions that are customized for application-specific performance.
  • The Company is headquartered in the United States, and has three European locations in Belgium, Germany, and Italy.

Headwall Bolsters Global Expansion with the Promotion of Key Team Members to Meet International Demand for Hyperspectral Imaging Solutions

Retrieved on: 
Thursday, March 18, 2021

Bolton, Massachusetts, March 18, 2021 (GLOBE NEWSWIRE) -- Headwall , the industry leader in turnkey hyperspectral imaging (HSI) solutions, announced today that Christian Felsheim has been promoted to Director Headwall EMEA and Francesco Beccari to Sales Manager Headwall EMEA.

Key Points: 
  • Bolton, Massachusetts, March 18, 2021 (GLOBE NEWSWIRE) -- Headwall , the industry leader in turnkey hyperspectral imaging (HSI) solutions, announced today that Christian Felsheim has been promoted to Director Headwall EMEA and Francesco Beccari to Sales Manager Headwall EMEA.
  • These promotions and expansion of responsibilities are reflective of the outstanding contributions Christian and Francesco have made while managing Headwalls European business and indicative of the growing global demand for Headwalls technology.
  • Global expansion is an important component to any companys growth strategy, said Don Battistoni, Vice President of Sales & Marketing.
  • Headwall is a leading designer and manufacturer of complete spectral instrumentation solutions for remote sensing, advanced machine vision, and government/defense markets.